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Background: Interpretation of binding modes of protein–small ligand complexes from 3D structure data is
essential for understanding selective ligand recognition by proteins. It is often performed by visual inspection and
sometimes largely depends on a priori knowledge about typical interactions such as hydrogen bonds and π-π stacking.
Because it can introduce some biases due to scientists’ subjective perspectives, more objective viewpoints considering
a wide range of interactions are required.
Description: In this paper, we present a web server for analyzing protein–small ligand interactions on the basis of
patterns of atomic contacts, or “interaction patterns” obtained from the statistical analyses of 3D structures of
protein–ligand complexes in our previous study. This server can guide visual inspection by providing information
about interaction patterns for each atomic contact in 3D structures. Users can visually investigate what atomic contacts
in user-specified 3D structures of protein–small ligand complexes are statistically overrepresented. This server consists
of two main components: “Complex Analyzer”, and “Pattern Viewer”. The former provides a 3D structure viewer with
annotations of interacting amino acid residues, ligand atoms, and interacting pairs of these. In the annotations of
interacting pairs, assignment to an interaction pattern of each contact and statistical preferences of the patterns are
presented. The “Pattern Viewer” provides details of each interaction pattern. Users can see visual representations of
probability density functions of interactions, and a list of protein–ligand complexes showing similar interactions.
Conclusions: Users can interactively analyze protein–small ligand binding modes with statistically determined
interaction patterns rather than relying on a priori knowledge of the users, by using our new web server named GIANT
that is freely available at http://giant.hgc.jp/.
Keywords: Molecular recognition, Ligand binding site, Protein–ligand interactions, Protein structure, Protein function,
Pattern recognition, Database, Web-serverBackground
Elucidating molecular mechanisms in the selective rec-
ognition of small molecules (or ligands) by proteins is a
central issue in biology. Structure data of protein–ligand
complexes deposited in Protein databank (PDB) [1] are a
very informative resource because the data contain direct
information of molecular interactions between proteins
and ligands at the atomistic scale. Structural biologists and
medicinal chemists can obtain implications and knowledge
through visual inspection of 3D structures of protein–* Correspondence: kengo@ecei.tohoku.ac.jp
1Graduate School of Information Sciences, Tohoku University, 6-3-09 Aoba,
Aramaki, Aoba-ku, Sendai, Miyagi 980-8597, Japan
2Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-cho,
Aoba-ku, Sendai, Miyagi 980-8573, Japan
Full list of author information is available at the end of the article
© 2014 Kasahara and Kinoshita; licensee BioM
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.ligand complexes. However, visual inspections by scientists
are subjective and may focus on only some particular well-
known interactions, e.g. hydrogen bonds. A more objective
and comprehensive view is required for the interpretation
of molecular interactions from 3D structure data.
Toward more objective analyses, a promising strategy
is taking advantages of statistics of molecular interac-
tions on PDB. Due to recent rapid increase in 3D struc-
ture data, this strategy has been become more attractive,
and the statistics of protein–ligand interactions have been
extensively studied [2]. Many secondary databases of PDB
focusing on protein–ligand complexes with various annota-
tions have been constructed [3-7]. Relibase [8], CREDO [9]
and PLI [10] particularly focus on atomic contacts between
proteins and ligands. They store information of protein–
ligand interactions at the atomistic level and provideed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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gen bonds, hydrophobic contacts and interactions of π-
systems. While they provide fruitful information about
protein–ligand interactions, analyses with these existing
databases are limited to well-known, preliminarily defined
atomic contacts. However, it is considered that the select-
ive molecular recognition is accomplished by combina-
tions of not only such typical interactions but also a huge
variety of atomic contacts. Comprehensive knowledge
about various kinds of atomic contacts is required.
Previously, we reported a comprehensive classification
of spatial arrangements of ligand atoms around molecular
fragments of proteins that were defined as three covalently
linked atoms [11]. We analyzed statistically preferred geo-
metries of the atomic contacts, or interaction patterns, as
mixtures of Gaussian functions. These interaction patterns
were obtained from every atomic contact observed in
PDB using an unsupervised pattern recognition approach
[12]. We found 13,512 interaction patterns in PDB and in-
teractions in these patterns were more enriched in native
complex structures than in docking decoys.
On the basis of the classification of interactions, we
present a new web server for analyzing molecular inter-
actions in the 3D structure of protein–ligand complexes,
named “GIANT”, which stands for “Gaussian mixture
model-based Interaction ANalyzer focusing on Three-atom
fragments”. GIANT provides a web browser-based user in-
terface for visual inspection of protein–ligand interactions
in 3D structures. Users can investigate how statistically
overrepresented each atomic contacts in the PDB, and what
protein–ligand complex uses similar interactions, for any
kind of atomic contacts rather than well-known predefined
types of interactions.
Construction and content
As in the previous paper, the dataset consists of 3D
structures of 66,654 protein–ligand binding sites from
23,040 PDB entries. These entries were chosen from a
snapshot of PDB on Sept. 25th, 2010 using following cri-
teria: (1) structures had been determined by X-ray crys-
tallography with resolution ≤2.5 Å, (2) receptor proteins
had ≥30 amino acid residues, and (3) bound ligands have
the molecular weight between 80 and 800 Da, contained >5
atoms, and had < 0.6 relative accessible surface area. For
each protein in the dataset, amino acids residues were
decomposed into fragments consisting of three covalently
linked atoms (Figure 1A). Ligand atoms were classified on
the basis of Tripos force field [13]. In the dataset, there
were 565 types of protein fragments and 27 types of ligand
atoms. From the complex structures, interacting pairs of
protein fragments and ligands atom were collected, and the
spatial distributions of interacting ligand atoms relative
to the protein fragments were considered (Figure 1B).
Then, a pattern recognition technique was applied to inferparameters of Gaussian mixture models with the best fits
to the spatial distributions, and 13,519 interaction patterns
(i.e., Gaussian functions) were found (Figure 1C) for 8,022
types of combinations of the protein fragment and ligand
atom. When the Mahalanobis distance between an inter-
action pattern and a position of atomic contacts, was ≤2.5,
the interaction pattern was annotated onto the contacting
pair. 63.4% of ligand atoms in our non-redundant dataset
were recognized by at least one interaction pattern; for
each complex, more than half of ligand atoms recognized
with at least one interaction pattern for the cases of 70.5%
of complexes. See our previous paper for details about the
statistics and the methods [11].
On the basis of the analyses, we constructed a web-based
application called GIANT, which consists of two main com-
ponents: “Complex Analyzer” and “Pattern Viewer”. The
former provides functionality to perform visual inspection
of protein–ligand interactions on the basis of annotations
of interaction patterns, and the latter shows a summary of
each interaction pattern.
Utility and discussion
We show two examples of analyses of protein–ligand in-
teractions. In the first example, a brief analysis of binding
modes of the dihydrofolate reductase (DHFR) and metho-
trexate (MTX) complex [PDB:3dfr] [14] was described in
a tutorial-style whitch instructs basic usage of GIANT.
The second one is a practical case that compares inter-
actions of two similar inhibitors recognized with the
same binding mode by identical cycline-dependent kin-
ase (CDK) [PDB:2r3j, 2r3k] [15].
Tutorial with a DHFR–methotrexate complex
We show a tutorial-style example for analyzing interac-
tions of a DHFR–methotrexate complex. In this example,
it is assumed that users want to know the molecular
mechanisms of methotrexate recognition by DHFR. We
here aim to study what kinds of statistically preferred in-
teractions are working on the recognition of the pteridine
ring and what other complexes apply similar interactions,
by using GIANT.
Users should first specify a query complex by designat-
ing a PDB-ID with a ligand 3-letter code or by uploading
a flat file in PDB format with specifying ligand 3-letter
code. Our example employs the former method. In this
flow, users should open the page “Complex Analyzer” at
the top page and input a PDB-ID with a ligand 3-letter
code such “3dfr_MTX” (Figure 2A). Following this, users
can observe the complex structure in the Jmol (http://
jmol.org/) applet (Figure 2B) by clicking the ‘load’ button
(Figure 2A).
On the right side of the window, there are three tables:
a list of interacting amino acid residues (Figure 2C), inter-




Figure 1 Methods for defining interaction patterns. (A) As an example of fragmentation of amino acid residues, the case of alanine is
illustrated, where eight fragments were obtained: N-CA-CB, C-CA-CB, C-CA-N, O–C-CA, and the fragments with the reverse orders. (B) Contacting
pairs of a protein fragment and a ligand atom were collected from the dataset. When the distance between the first atom of the fragment and
the ligand atom was less than the criterion (the sum of van der Waals radii plus the offset value 1.0 Å), the pair was sampled. Sampled contacting
pairs formed a 3D spatial distribution on the basis of reference coordinates defined by the three atoms in the protein fragment. Three arrows
indicate the axes of the reference coordinate system, “CA-C-O” is a protein fragment, and “C3” in circles denote positions of interacting ligand
atoms observed in the dataset (“C3” means a type of ligand atom i.e., a sp3 carbon atom). (C) A pattern recognition technique was applied to
each 3D spatial distribution. Interaction patterns were defined as Gaussian mixture distributions.
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view interactions in the Jmol viewer by clicking check
boxes in the tables. For example, they can focus on inter-
actions of the 2′ amino group in the pteridine ring in
MTX by filling the corresponding check box (Atom-ID = 3)
in the table of ligand atoms. Amino acid residues recogniz-
ing the specified atom will then appear, and interactions
will be depicted as lines between atoms (Figure 2B). Fur-
thermore, the table of interaction collectively shows a list of
interactions of the specified atom. In this case, the nitrogen
atom composing the amino group is recognized by three
residues: Ala6, Asp26 and Thr116. The interaction with
Asp26 is a bifurcated hydrogen bond. This interaction pat-
tern (Pattern-ID = 18713) was widely observed in the data-
set, i.e., 952 interactions in 63 protein families (defined by asingle-linkage cluster of amino acid sequences within 25%
sequence identity with ≥50% sequence coverage) were as-
signed to this pattern. These values are described in the col-
umn “Freq.” and “Family” in the table of interactions. Users
can also see the competence of this interaction to a prob-
ability distribution by checking the value in the column
“Prob.” that denotes the probability density of this data
point in the Gaussian mixture distribution. In contrast to
that the interaction pattern of Asp26 with the nitrogen
atom that is a common feature in a wide range of protein
families, the interaction with Thr116 was observed only in
five protein families. This interaction pattern is almost spe-
cific to the DHFR family (This residue recognizes the ligand
via an intermediate water molecule. Although GIANT does







Click a Pattern-ID to jump
to “Pattern Viewer” . 
Click “C” to see lists of
ligands and complexes
with the pattern.




Figure 2 Screenshots of GIANT consisting of the two parts: complex analyzer (A-E) and pattern viewer (F-I). (A) Query input box. (B) 3D
structure viewer for a query protein–ligand complex. (C) List of interacting residues. (D) List of interacting ligand atoms. (E) List of interactions.
(F) 3D viewer for spatial distribution of interaction patterns. The red contour is the interaction pattern that is specified in Complex Analyzer by
users. (G) List of interaction patterns. The row shown in red corresponds to the red contour in the 3D viewer. (H) List of ligands recognized with
a user-specified interaction pattern. (I) List of protein–ligand complexes using a user-specified interaction pattern.
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contacting atoms are below a threshold, calculated as sum
of van der Waals radii and 1.0 Å).
While “Complex Analyzer” provides information about
assignments of atomic contacts to interaction patterns for
user-specified complexes, it is still difficult to interpret the
nature of each interaction pattern using only this compo-
nent. The alternative component “Pattern Viewer” helps
analyses by providing graphical information about the 3D
spatial probability distribution of each interaction pattern.
Users can jump to this component by clicking “Pattern-
ID” in any row of the table of interactions. To see the
interaction patterns with Asp26, click “18713” (the seventh
column) of the row with Interaction-ID = 101 (the first
column) in the table of interactions. The “Pattern Viewer”
page will be opened and will show the spatial distribution
of each interaction pattern as 3D meshes (Figure 2F).
Three covalently linked atoms centered in the viewer rep-
resent a fragment of proteins. The regions inside of the
meshes are statistically preferred positions of ligand atoms
for interaction with the fragment. The contour of thepattern specified in the “Complex Analyzer” is highlighted
in red. Clicking “C” in the right table (Figure 2G) provides
a list of ligands (Figure 2H) and that of protein–ligand
complexes (Figure 2I) with the same interaction patterns.
This information may be useful for seeking complexes
with similar interactions to the query.
Comparing interactions of two CDK inhibitors
Subtle structural differences in a compound can drastic-
ally change its binding affinity to a target protein without
disruption of hydrogen bonds and such well-known inter-
actions. Since the complexity in structure–activity rela-
tionships is a major barrier in drug discovery projects,
understanding preferences of interactions in each atom
is important. GIANT provides some clues to that from
the statistical perspective. As an example, we show ana-
lyses on differences between two similar ligands binding
with an identical target protein, CDK. The structures of
these two ligands were shown in Figure 3A [PDB: 2r3j]
and B [PDB: 2r3k] (they were not in the pre-calculated















Figure 3 Differences in interactions between two similar compounds bound with an identical target protein, CDK. (A, B) Screenshots of
Complex Analyzer for [PDB: 2r3j] and [PDB: 2r3k]. Circles I and II indicate altered atoms between these two ligands. Three amino acid residues
interacted with these two altered atoms, i.e., Ile10, His84, and Leu134, were shown as a stick model. Pink and Cyan arrows emphasizes
interactions in patterns, and they corresponds to the panel (C, D) and (E), respectively. (C, D, E, F) Screenshots of Pattern Viewer about the
interactions of Leu Cδ-Cγ-Cβ fragments with aromatic nitrogen atoms (C) and with aromatic carbon atoms (D), and those of His O-C-N with
aromatic carbon atoms (E) and aromatic nitrogen atoms (F).
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gands were only two atoms, that marked as I and II in
Figure 3A and B, IC50 value of the ligand in 2r3j was
10-fold lower than that in 2r3k [15]. What makes this
significant difference in binding affinity is unclear, be-
cause these atoms did not make hydrogen bonds with
the binding sites and there was no significant structural
change in amino acid residues in binding sites.
While one of the two altered parts in the ligands had
similar interactions between 2r3j and 2r3k, the other
one had distinct interactions. In the position I, that was
an aromatic nitrogen atom and aromatic carbon atom in
2r3j and 2r3k, respectively, interacted with Leu134 resi-
due by a CH–π interaction. The spatial distributions of
aromatic nitrogen and carbon atoms interacting with Leu
Cδ–Cγ–Cβ fragment were similar (Figure 3C and D, re-
spectively), and both of patterns used in these atoms
(shown as red contours) were widely shared in many pro-
tein families (89 and 174 families shares the patterns for
aromatic nitrogen and aromatic carbon atoms, respect-
ively). On the other hand, the position II, that is an aro-
matic carbon atom in 2r3j and an aromatic nitrogen atom
in 2r3k, contacted with Ile10 side-chain and His84 main-
chain. While interactions between Ile10 and the position
II was in a pattern for the both complexes, that between
His84 and the position II were in a pattern only for the
complex 2r3k (position II was an aromatic carbon atom)
despite of there was no significant structural changes
(interatomic distance between the His84 backbone oxygen
atom and the contacting ligand atoms were 3.7 Å and
3.6 Å in 2r3j and 2r3k, respectively). In contrast to the
spatial distribution of aromatic carbon atoms around HisO–C-N fragment (Figure 3E), that of aromatic nitrogen
atoms preferred only one configuration of interactions
(Figure 3F). This result implies that this loss of the statisti-
cally preferred interactions with His84 main chain causes
10-fold gain of IC50 value in 2r3k complex from 2r3j, and
the position II should be a carbon atom rather than a ni-
trogen atom for higher affinity. This should be a helpful
information for medicinal chemists.
Future perspective
Although the scope of GIANT is limited to the direct
contacts between proteins and small molecules in the
current version, the basic concept of GIANT is applicable
to other various kinds of molecular interactions such as
water-mediated interactions. In the future developments,
we are planning taking statistics of interactions with metal
and water molecules that play important roles for molecu-
lar recognitions. In addition, while the interaction patterns
defined in GIANT focuses on the relative positions be-
tween a protein fragment and a ligand atom, and does not
consider the combination of the elements interactions (or
the “environment” around the contacting pair). The infor-
mation about environment should be an important factor
in the ligand recognition, we will take some statistics of co-
occurrences of the interaction patterns in a future work.
Conclusions
The web-server GIANT shows the statistical preferences
of each atomic contact in user specified 3D structures of
protein–small ligand complexes. This function provides an
objective perspective for visual inspections of binding
modes on the basis of results of the survey of interactions
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plications for structural biologists and medicinal chem-
ists. For example, when medicinal chemists perform lead
optimization with 3D structure data of protein–compound
complexes, GIANT suggests parts of compounds where
chemical moieties without statistically overrepresented in-
teraction patterns should be replaced to gain binding affin-
ities. Although this process has usually been performed by
experts using their a priori knowledge and intuition,
GIANT supports it with statistical, objective information
and assists in realizing the concept of so-called rational
drug-design.
Availability and requirement
GIANT is freely available at the following URL: http://
giant.hgc.jp/.
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